As we age, most aspects of the immune system deteriorate. This aging effect put the elderly at greater risk of infections including RSV (Respiratory Syncytial Virus). RSV infection can be severe for older adults, especially those who have certain medical conditions. Since RSV usually causes cold-like symptoms, it is often left undiagnosed and untreated properly.
Mortality rate of RSV infections in the elderly is approximately 12%
compared to RSV-associated mortality in children 0.12%
RSV causes infections of the lungs and respiratory tract. There is no specific medication for RSV infection. Treatment involves symptomatic care which may vary among individuals. RSV-associated mortality rate in the elderly is considerably higher compared to children. Disease severity increases in those with underlying conditions, such as respiratory diseases (asthma and chronic obstructive pulmonary disease or COPD) and chronic diseases (e.g. diabetes, kidney disease and heart disease). The RSV vaccine helps strengthen the immune system while minimizing the risk of infection and disease severity. More importantly, it helps reduce RSV-associated mortality in the elderly.
Boost up senior’s immunity with RSV Vaccine Package for Older Adults – 8,990 THB/shot
Who should be vaccinated?
- Elderly adults aged over 75 years old
- People over 60-74 years old with any one of underlying diseases (e.g. heart disease, asthma, COPD, emphysema, kidney disease, diabetes and obesity) as well as immunocompromised patients
Additional information
- An overall efficacy to protect against RVS 82.6%
- An efficacy against severe disease 94.1%
- A single dose is advised
- Avoid RSV vaccine during pregnancy or breastfeeding
